Reported 23 days ago
In the first quarter of 2025, Tempus AI, Inc. (NASDAQ:TEM) experienced a significant stock gain of 43% as per Frontier Capital Management’s investor letter, primarily attributed to robust growth and the conclusion of its IPO lockup period. The healthcare technology company, known for its advanced diagnostics and analytics capabilities, reported a remarkable 75.4% year-over-year revenue increase to $255.7 million. Despite being unprofitable, Tempus projected positive EBITDA for the year, enhancing its appeal to investors amidst a challenging equity market.
Source: YAHOO